XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
VLTO Veralto Corp
- 97.990
- -1.760-1.76%
Close Feb 14 16:00 ET
- 97.990
- 0.0000.00%
Post 20:01 ET
24.23BMarket Cap29.34P/E (TTM)
99.990High97.980Low974.52KVolume99.990Open99.750Pre Close96.02MTurnover0.41%Turnover Ratio29.34P/E (Static)247.31MShares114.89052wk High11.85P/B23.20BFloat Cap83.00152wk Low0.38Dividend TTM236.80MShs Float114.890Historical High0.39%Div YieldTTM2.02%Amplitude65.148Historical Low98.527Avg Price1Lot Size
Veralto Corp Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 27, 2024 | (Q2)Jun 28, 2024 | (Q1)Mar 29, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 29, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.14%875M | 8.37%285M | -7.82%224M | -16.61%251M | -26.28%115M | 10.69%963M | -21.96%263M | -5.45%243M | 301M | 156M |
| Net income from continuing operations | -0.72%833M | 13.50%227M | 6.83%219M | -2.87%203M | -18.22%184M | -0.71%839M | -7.41%200M | -5.96%205M | --209M | --225M |
| Depreciation and amortization | -10.34%78M | -9.09%20M | -19.05%17M | -9.09%20M | -4.55%21M | -3.33%87M | 4.76%22M | 0.00%21M | --22M | --22M |
| Other non cash items | --15M | ---- | ---- | --0 | --15M | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -251.52%-116M | 19.05%25M | -825.00%-29M | -80.95%8M | -20.00%-120M | 68.87%-33M | -76.40%21M | -60.00%4M | --42M | ---100M |
| -Change in receivables | ---- | ---- | -22.22%-22M | -26.67%11M | 300.00%4M | 102.27%2M | -66.67%4M | -50.00%-18M | --15M | --1M |
| -Change in inventory | ---- | ---- | -166.67%-8M | -127.78%-5M | -550.00%-13M | 236.84%52M | -25.00%24M | 1,100.00%12M | --18M | ---2M |
| -Change in prepaid assets | ---- | ---- | -44.44%-13M | -64.71%6M | 0.00%-9M | -980.00%-54M | -783.33%-53M | -350.00%-9M | --17M | ---9M |
| -Change in payables and accrued expense | ---- | ---- | -26.32%14M | 50.00%-4M | -13.33%-102M | -111.59%-8M | -25.26%71M | -17.39%19M | ---8M | ---90M |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | 43.18%-25M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.14%875M | 8.37%285M | -7.82%224M | -16.61%251M | -26.28%115M | 10.69%963M | -21.96%263M | -5.45%243M | --301M | --156M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -689.09%-434M | -1,690.91%-394M | 57.14%-6M | -10.00%-11M | -155.56%-23M | 38.20%-55M | -83.33%-22M | 67.44%-14M | -10M | -9M |
| Net PPE purchase and sale | -5.77%-55M | 0.00%-22M | 0.00%-9M | 8.33%-11M | -44.44%-13M | -52.94%-52M | -175.00%-22M | -50.00%-9M | ---12M | ---9M |
| Net business purchase and sale | ---363M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | -433.33%-16M | ---9M | 160.00%3M | --0 | ---10M | ---3M | --0 | ---5M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -689.09%-434M | -1,690.91%-394M | 57.14%-6M | -10.00%-11M | -155.56%-23M | 38.20%-55M | -83.33%-22M | 67.44%-14M | ---10M | ---9M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 51.85%-65M | -116.49%-16M | -107.77%-16M | 95.53%-13M | 86.39%-20M | 82.71%-135M | 129.85%97M | 196.26%206M | -291M | -147M |
| Net issuance payments of debt | --0 | --0 | ---- | ---- | ---- | --2.61B | --0 | ---- | ---- | ---- |
| Net common stock issuance | --0 | -119.35%-18M | -96.46%7M | 102.05%9M | --2M | 81.18%-147M | 128.62%93M | 192.52%198M | ---438M | --0 |
| Cash dividends paid | ---89M | ---22M | ---23M | ---22M | ---22M | ---- | ---- | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 500.00%24M | ---- | ---- | ---- | ---- | --4M | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---2.6B | --0 | ---- | ---- | ---147M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 51.85%-65M | -116.49%-16M | -107.77%-16M | 95.53%-13M | 86.39%-20M | 82.71%-135M | 129.85%97M | 196.26%206M | ---291M | ---147M |
| Net cash flow | ||||||||||
| Beginning cash position | --762M | 197.42%1.27B | --1.04B | --827M | --762M | --0 | --426M | --0 | --0 | --0 |
| Current changes in cash | -51.36%376M | -136.98%-125M | --202M | --227M | --72M | --773M | --338M | ---- | ---- | ---- |
| Effect of exchange rate changes | -236.36%-37M | -1,950.00%-41M | 344.44%22M | ---11M | ---7M | ---11M | ---2M | ---9M | --0 | --0 |
| End cash Position | 44.49%1.1B | 44.49%1.1B | 197.42%1.27B | --1.04B | --827M | --762M | --762M | --426M | --0 | --0 |
| Free cash flow | -9.79%820M | 9.13%263M | -7.33%215M | -16.96%240M | -30.61%102M | 8.73%909M | -26.75%241M | -7.57%232M | --289M | --147M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?